Growth Metrics

Ocugen (OCGN) Operating Income (2016 - 2025)

Ocugen (OCGN) has disclosed Operating Income for 12 consecutive years, with -$17.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income fell 22.8% year-over-year to -$17.0 million, compared with a TTM value of -$62.9 million through Dec 2025, down 14.9%, and an annual FY2025 reading of -$62.9 million, down 14.9% over the prior year.
  • Operating Income was -$17.0 million for Q4 2025 at Ocugen, up from -$17.6 million in the prior quarter.
  • Across five years, Operating Income topped out at -$7.1 million in Q1 2021 and bottomed at -$28.4 million in Q4 2022.
  • Average Operating Income over 5 years is -$16.7 million, with a median of -$15.0 million recorded in 2021.
  • The sharpest move saw Operating Income tumbled 660.84% in 2021, then skyrocketed 59.35% in 2023.
  • Year by year, Operating Income stood at -$14.6 million in 2021, then tumbled by 94.57% to -$28.4 million in 2022, then surged by 59.35% to -$11.5 million in 2023, then dropped by 20.09% to -$13.8 million in 2024, then dropped by 22.8% to -$17.0 million in 2025.
  • Business Quant data shows Operating Income for OCGN at -$17.0 million in Q4 2025, -$17.6 million in Q3 2025, and -$13.8 million in Q2 2025.